Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dna X (SONM) Invested Capital (2018 - 2025)

Dna X's Invested Capital history spans 8 years, with the latest figure at -$7.8 million for Q4 2025.

  • Quarterly results put Invested Capital at -$7.8 million for Q4 2025, down 36.56% from a year ago — trailing twelve months through Dec 2025 was -$7.8 million (down 36.56% YoY), and the annual figure for FY2025 was -$7.8 million, down 36.56%.
  • Invested Capital for Q4 2025 was -$7.8 million at Dna X, down from -$701000.0 in the prior quarter.
  • In the past five years, Invested Capital ranged from a high of $23.1 million in Q3 2023 to a low of -$7.8 million in Q4 2025.
  • The 5-year median for Invested Capital is $16.4 million (2024), against an average of $12.4 million.
  • The sharpest move saw Invested Capital soared 203.69% in 2023, then crashed 125.48% in 2024.
  • Year by year, Invested Capital stood at $18.8 million in 2021, then increased by 7.53% to $20.2 million in 2022, then grew by 10.78% to $22.4 million in 2023, then crashed by 125.48% to -$5.7 million in 2024, then crashed by 36.56% to -$7.8 million in 2025.
  • According to Business Quant data, Invested Capital over the past three periods came in at -$7.8 million, -$701000.0, and -$1.3 million for Q4 2025, Q3 2025, and Q2 2025 respectively.